Kalkine has a fully transformed New Avatar.

small-cap

Latest with 2 Artificial Intelligence Related Stocks - BrainChip Holdings Ltd and Appen Ltd

Aug 07, 2018 | Team Kalkine
Latest with 2 Artificial Intelligence Related Stocks - BrainChip Holdings Ltd and Appen Ltd

BrainChip Holdings Ltd

Securing first Technical Sales Partner in Scandinavia: BrainChip Holdings Ltd.’s (ASX: BRN) stock was up 5.88% on August 06, 2018 as the leading neuromorphic computing company inked a strategic partnership with Telesikring, which is Denmark’s largest Danish-owned installer of security solutions for small, medium and large companies. This joint move will help cater to the law enforcement requirements and end users will be able to efficiently classify suspects in a faster manner with the help of BRN’s BrainChip Studio, an award-winning AI powered software platform for object recognition and facial classification that was launched last year. This paves the path for an integrated analytics solutions’ platform for video security and surveillance. While BRN will provide its platform, Telesikring will promote, install, and support BrainChip’s growing portfolio of AI-powered software and hardware solutions across existing and new video security customer base. BRN thus aims to benefit from the growing Danish security market based on video surveillance services, and this is estimated to grow to DKK 845 million by 2022. In last one month, the stock has been up 36%, as at August 06, 2018, and has been an interesting play. BRN traded at $ 0.180 as at August 06, 2018.
 

Appen Ltd

Latest stock price plunge: Appen Ltd (ASX: APX) will be releasing its earnings for half year ended 30 June 2018 on 28 August 2018. In last one year, the stock has risen 175.5% but fell 13% in last one month. The group’s underlying EBITDA was $28.1m, reflecting a growth of 62% while statutory EBITDA was up by 29%. The Underlying NPAT is $19.7m, which was up by 86%. The Underlying EBITDA margin improvement from 15.6% to 16.9%. has been decent with revenue growth on a constant currency to be 11%. However, full year underlying EBITDA for the year will come at around upper end of $50m - $55m (at A$1 = US$0.80). This global leader in the development of high quality, human-annotated datasets for artificial intelligence is a key to watch while it still trades at higher levels despite the latest stock price slump. APX traded at $ 11.280 as at August 06, 2018.



Disclaimer
 
The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. Kalkine.com.au and associated pages are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). The information on this website has been prepared from a wide variety of sources, which Kalkine Pty Ltd, to the best of its knowledge and belief, considers accurate. You should make your own enquiries about any investments and we strongly suggest you seek advice before acting upon any recommendation. Kalkine Pty Ltd has made every effort to ensure the reliability of information contained in its newsletters and websites. All information represents our views at the date of publication and may change without notice. To the extent permitted by law, Kalkine Pty Ltd excludes all liability for any loss or damage arising from the use of this website and any information published (including any indirect or consequential loss, any data loss or data corruption). If the law prohibits this exclusion, Kalkine Pty Ltd hereby limits its liability, to the extent permitted by law to the resupply of services. There may be a product disclosure statement or other offer document for the securities and financial products we write about in Kalkine Reports. You should obtain a copy of the product disclosure statement or offer document before making any decision about whether to acquire the security or product. The link to our Terms & Conditions has been provided please go through them and also have a read of the Financial Services Guide. On the date of publishing this report (mentioned on the website), employees and/or associates of Kalkine Pty Ltd do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.